172 related articles for article (PubMed ID: 21313999)
1. Production and immunogenicity of hypoallergenic codon-optimized DNA vaccine encoding mature Der p 1 allergen.
Pulsawat P; Piboonpocanun S; Sirivichayakul S; Buranapraditkun S; Jacquet A; Shimada M; Okuda K; Ruxrungtham K
J Investig Allergol Clin Immunol; 2010; 20(7):582-90. PubMed ID: 21313999
[TBL] [Abstract][Full Text] [Related]
2. Absence of immunoglobulin E synthesis and airway eosinophilia by vaccination with plasmid DNA encoding ProDer p 1.
Jacquet A; Magi M; Haumont M; Jurado M; Garcia L; Bollen A
Clin Exp Allergy; 2003 Feb; 33(2):218-25. PubMed ID: 12580915
[TBL] [Abstract][Full Text] [Related]
3. A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines.
Walgraffe D; Mattéotti C; El Bakkoury M; Garcia L; Marchand C; Bullens D; Vandenbranden M; Jacquet A
J Allergy Clin Immunol; 2009 May; 123(5):1150-6. PubMed ID: 19152967
[TBL] [Abstract][Full Text] [Related]
4. A DNA vaccine encoding a chimeric allergen derived from major group 1 allergens of dust mite can be used for specific immunotherapy.
Sun T; Yin K; Wu LY; Jin WJ; Li Y; Sheng B; Jiang YX
Int J Clin Exp Pathol; 2014; 7(9):5473-83. PubMed ID: 25337189
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic lipid DiC14-amidine prevents allergic responses to house dust mite.
Jacquet A; Vanderschrick JF; Vandenbranden M; Elouahabi A; Magi M; Garcia L; Ruysschaert JM
Mol Ther; 2005 Jun; 11(6):960-8. PubMed ID: 15922967
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model.
Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS
Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083
[TBL] [Abstract][Full Text] [Related]
7. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
[TBL] [Abstract][Full Text] [Related]
8. Heat denaturation affects the ProDer p 1 IgE reactivity and downregulates the development of the specific allergic response.
Magi M; Garcia L; Vandenbranden M; Palmantier R; Jacquet A
J Allergy Clin Immunol; 2004 Sep; 114(3):545-52. PubMed ID: 15356555
[TBL] [Abstract][Full Text] [Related]
9. Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy.
Bouaziz A; Walgraffe D; Bouillot C; Herman J; Foguenne J; Gothot A; Louis R; Hentges F; Jacquet A; Mailleux AC; Chevigné A; Galleni M; Adam E; Dumez ME
Clin Exp Allergy; 2015 Apr; 45(4):823-34. PubMed ID: 25406386
[TBL] [Abstract][Full Text] [Related]
10. The chitinase allergens Der p 15 and Der p 18 from Dermatophagoides pteronyssinus.
O'Neil SE; Heinrich TK; Hales BJ; Hazell LA; Holt DC; Fischer K; Thomas WR
Clin Exp Allergy; 2006 Jun; 36(6):831-9. PubMed ID: 16776685
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular immunization with DNA construct containing Der p 2 and signal peptide sequences primed strong IgE production.
Tan LK; Huang CH; Kuo IC; Liew LM; Chua KY
Vaccine; 2006 Jul; 24(29-30):5762-71. PubMed ID: 16740347
[TBL] [Abstract][Full Text] [Related]
12. Optimization of a Der p 2-based prophylactic DNA vaccine against house dust mite allergy.
Pulsawat P; Pitakpolrat P; Prompetchara E; Kaewamatawong T; Techakriengkrai N; Sirivichayakul S; Buranapraditkun S; Hannaman D; Ruxrungtham K; Jacquet A
Immunol Lett; 2013 Mar; 151(1-2):23-30. PubMed ID: 23396105
[TBL] [Abstract][Full Text] [Related]
13. Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy.
Weghofer M; Grote M; Dall'Antonia Y; Fernández-Caldas E; Krauth MT; van Hage M; Horak F; Thomas WR; Valent P; Keller W; Valenta R; Vrtala S
Int Arch Allergy Immunol; 2008; 147(2):101-9. PubMed ID: 18520154
[TBL] [Abstract][Full Text] [Related]
14. Suppression of allergen-specific B lymphocytes by chimeric protein-engineered antibodies.
Kerekov N; Michova A; Muhtarova M; Nikolov G; Mihaylova N; Petrunov B; Nikolova M; Tchorbanov A
Immunobiology; 2014 Jan; 219(1):45-52. PubMed ID: 24021574
[TBL] [Abstract][Full Text] [Related]
15. Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination.
Draghi M; Jarman ER; Grifantini R; Galli-Stampino L; Lamb JR; Valiante NM; Grandi G
Eur J Immunol; 2002 Dec; 32(12):3720-8. PubMed ID: 12516566
[TBL] [Abstract][Full Text] [Related]
16. Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy.
Chen KW; Blatt K; Thomas WR; Swoboda I; Valent P; Valenta R; Vrtala S
J Allergy Clin Immunol; 2012 Aug; 130(2):435-43.e4. PubMed ID: 22789398
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization with DNA vaccine coexpressing Der p 1 and ubiquitin in an allergic rhinitis mouse model.
Ou J; Shi W; Xu Y; Tao Z
Ann Allergy Asthma Immunol; 2014 Dec; 113(6):658-665.e1. PubMed ID: 25240330
[TBL] [Abstract][Full Text] [Related]
18. Expression and immunogenicity of the major house dust mite allergen Der p 1 following DNA immunization.
Wolfowicz CB; HuangFu T; Chua KY
Vaccine; 2003 Mar; 21(11-12):1195-204. PubMed ID: 12559798
[TBL] [Abstract][Full Text] [Related]
19. Dust mite allergen Der f 4: Expression, characterization, and IgE binding in pediatric asthma.
Cui YB; Yu LL; Teng FX; Wang N; Zhou Y; Yang L; Zhang CB
Pediatr Allergy Immunol; 2016 Jun; 27(4):391-7. PubMed ID: 26842967
[TBL] [Abstract][Full Text] [Related]
20. High-level expression in mammalian cells of recombinant house dust mite allergen ProDer p 1 with optimized codon usage.
Massaer M; Mazzu P; Haumont M; Magi M; Daminet V; Bollen A; Jacquet A
Int Arch Allergy Immunol; 2001 May; 125(1):32-43. PubMed ID: 11385286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
